Please login to the form below

Not currently logged in
Email:
Password:

Ready to Engage

Recent events have brought to a head Europe's discord over the practice of parallel trade

Recent events have brought to a head Europe's discord over the practice of parallel trade. Opinions on its value are diametrically opposed, with some condemning it as a danger to patients and others asserting that it generates savings for healthcare systems. A key point of current debate, however, is whether it lets criminal counterfeiters into the supply chain

The argument against parallel trade
Some feel that parallel trade weakens security, enabling drug counterfeiters to enter and pollute legitimate supply chains
Read more

The argument for parallel trade
others believe that today's well-regulated parallel trade creates much-needed savings for europe's healthcare systems
Read more

Pharma speaks out
glaxosmithkline has recently experienced victory over parallel traders in greek courts - Alice Hunt talks about the outcomes
Read more

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics